The DOI matches its Crossref record; 657 of the 657 references it cites were found in a registry or an index.
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Open accessAbstract
... Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. A great number of Guidelines have been issued in recent years by the European Society of Cardiology (ESC) as well as by other societies and organisations. Because of the impact on clinical practice, quality criteria for the development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines can be found on the ESC website (http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Guidelines-development/Writing-ESC-Guidelines). ESC Guidelines represent the official position of the ESC on a given topic and are regularly updated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There are in fact many treatments proven to improve symptoms, but they are infrequently employed because of a neutral (or negative) effect on disease progression including diuretics, dobutamine, and morphine. 21”
From Prioritizing symptom management in the treatment of chronic heart failure (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredIn the citing paper
“There are no specific constraints to HF treatment in T2DM patients as recommended by the 2016 ESC guidelines for the management of HF. 116”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [116]
In the citing paper
“as they have been shown to improve symptoms and reduce morbidity and mortality.116”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Faris, R. F., Flather, M. D., Purcell, H., Poole-Wilson, P. A., & Coats, A. J. S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003838.pub3 · Cited by 165
Self-citationRetractedFolstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
Self-citationEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Flagged first, then by citations
Research works printed but not linked: 5
- Beckett, 2008, Treatment of hypertension in patients 80 years of age or older, N Engl J Med, 358, 1887, 10.1056/NEJMoa0801369 · DOI · Paper page
- Sciarretta, 2011, Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk, Arch Intern Med, 171, 384, 10.1001/archinternmed.2010.427 · DOI
- Zamorano, 2016, 2016 Position paper on anticancer treatments and cardiovascular toxicity, Eur Heart J, 10.1093/eurheartj/ehw211 · DOI
- Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 · DOI · Paper page
- Rahmel, 2013, Eurotransplant International Foundation Annual Report 2013
Cited by
Sorted by citations
Items 401–500 of 1,013
Núñez, J. E., Miñana, G., Cardells, I., Palau, P., Llàcer, P., Fácila, L., Almenar, L., López-Lereu, M. P., Monmeneu, J. V., Amiguet, M., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014254 · Cited by 93
Dewan, P., Jackson, A. M., Lam, C. S. P., Pfeffer, M. A., Zannad, F. M., Pitt, B., Solomon, S. D., & McMurray, J. J. V. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1776 · Cited by 93
Prolonged Weaning: S2k Guideline Published by the German Respiratory Society
Schönhofer, B., Geiseler, J. G., Dellweg, D., Fuchs, H. W., Moerer, O., Weber‐Carstens, S., Westhoff, M., & Windisch, W. (2020) · Respiration · doi:10.1159/000510085 · Cited by 99
Ginsenoside Re attenuates myocardial ischemia/reperfusion induced ferroptosis via miR-144-3p/SLC7A11
Ye, J., Lyu, T.-J., Li, L., Liu, Y., Zhang, H., Wang, X., Xi, X., Liu, Z.-J., & Gao, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154681 · Cited by 96
Cardiac metabolism — A promising therapeutic target for heart failure
Noordali, H., Loudon, B. L., Frenneaux, M. P., & Madhani, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.001 · Cited by 94
Cuthbert, J. J., Pellicori, P., Rigby, A. S., Pan, D., Kazmi, S., Shah, P. P., & Clark, A. L. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1247 · Cited by 92
Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field
Asmarats, L., Taramasso, M., & Rodés‐Cabau, J. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0186-1 · Cited by 92
Multidisciplinary Code Shock Team in Cardiogenic Shock: A Canadian Centre Experience
Lee, F., Hutson, J. H., Boodhwani, M., McDonald, B. J., So, D. Y. F., Roock, S. D., Rubens, F. D., Stadnick, E., Ruel, M., May, M. R. L., et al. (2020) · CJC Open · doi:10.1016/j.cjco.2020.03.009 · Cited by 92
Wideqvist, M., Cui, X., Magnusson, C., Schaufelberger, M., & Fu, M. L. X. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13221 · Cited by 92
Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options
Pastena, P., Frye, J. T., Ho, C., Goldschmidt, M. E., & Kalogeropoulos, A. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10377-4 · Cited by 90
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
Ferreira, J. P., Zannad, F. M., Butler, J., Filipattos, G., Ritter, I., Schueler, E., Kraus, B. J., Pocock, S., Anker, S. D., & Packer, M. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac306 · Cited by 92
Self-citationBeggs, S. A. S., Jhund, P. S., Jackson, C. E., McMurray, J. J. V., & Gardner, R. S. (2017) · Heart · doi:10.1136/heartjnl-2016-310850 · Cited by 90
Merlo, M., Cannata, A. N., Gava, C. P. L. D., Stolfo, D., Barbati, G., Artico, J., Gentile, P., Paris, V. D., Ramani, F., Zecchin, M., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1914 · Cited by 90
Wang, C., Chan, Y., Wu, V. C., Lee, H., Hsiao, F., & Chu, P. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa162 · Cited by 90
Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs
Shrivastava, A., Haase, T., Zeller, T., & Schulte, C. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.601364 · Cited by 92
Sliwa, K. S., van der Meer, P., Petrie, M. C., Frogoudaki, A., Johnson, M. R., Hilfiker‐Kleiner, D., Hamdan, R., Jackson, A. M., Ibrahim, B., Mbakwem, A. C., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2133 · Cited by 97
Self-citationTrevisan, M., Fu, E. L., Xu, Y., Savarese, G., Dekker, F. W., Lund, L. H., Clase, C. M., Sjölander, A., & Carrero, J. J. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2287 · Cited by 93
Uhlig, K., Efremov, L., Tongers, J., Frantz, S., Mikolajczyk, R., Sedding, D., & Schumann, J. E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009669.pub4 · Cited by 91
Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions
Lund, L. H., Oldgren, J., & James, S. K. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0325-0 · Cited by 91
Prognostic power of left atrial strain in patients with acute heart failure
Park, J., Hwang, I., Park, J. J., Park, J., & Cho, G. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa013 · Cited by 89
Harjola, V., Parissis, J., Bauersachs, J. K., Rocca, H. B., Bueno, H., Čelutkienė, J., Chioncel, O. D., Coats, A. J. S., Collins, S. P., de Boer, R. A., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1831 · Cited by 92
Self-citationMetabolomic Profile in HFpEF vs HFrEF Patients
Hage, C., Löfgren, L., Michopoulos, F., nilsson, R., Davidsson, P., Kumar, C., Ekström, M., Eriksson, M. J., Lyngå, P., Persson, B., et al. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.07.010 · Cited by 87
Self-citationReza, N., Tahhan, A. S., Mahmud, N., DeFilippis, E. M., Alrohaibani, A., Vaduganathan, M., Greene, S. J., Ho, A., Fonarow, G. C., Butler, J., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006605 · Cited by 89
Self-citationSze, S., Pellicori, P., Zhang, J., Weston, J., & Clark, A. L. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa311 · Cited by 89
Tolppanen, H., Rivas‐Lasarte, M., Lassus, J. P. E., Sans‐Roselló, J., Hartmann, O., Lindholm, M. G., Arrigo, M., Tarvasmäki, T., Køber, L., Thiele, H., et al. (2017) · Annals of Intensive Care · doi:10.1186/s13613-016-0229-2 · Cited by 88
Self-citationLiver disease and heart failure: Back and forth
Correale, M., Tarantino, N. M., Petrucci, R., Tricarico, L., Laonigro, I., Biase, M. D., & Brunetti, N. D. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.10.016 · Cited by 88
Bavendiek, U., Berliner, D., Dávila, L. A., Schwab, J., Maier, L. S., Philipp, S., Rieth, A. J., Westenfeld, R., Piorkowski, C., Weber, K., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1452 · Cited by 89
Miró, Ò., Sarasola, A. G., Fuenzalida, C., Calderón, S., Jacob, J., Aguirre, A., Wu, D. M., Rizzi, M. A., Malchair, P., Haro, A., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1567 · Cited by 88
Self-citationHeart failure with preserved ejection fraction: insights into diagnosis and pathophysiology
Nagueh, S. F. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa228 · Cited by 96
Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
Conti, V., Corbi, G., Polito, M. V., Ciccarelli, M., Manzo, V., Torsiello, M., Bellis, E. D., D’Auria, F., Vitulano, G., Piscione, F., et al. (2020) · Biomolecules · doi:10.3390/biom10111590 · Cited by 88
Zou, H., Chen, Y., Fang, W., Zhang, Y., & Fan, X. (2017) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515117695722 · Cited by 87
Abdu, F. A., Liu, L., Mohammed, A., Luo, Y., Xu, S., Auckle, R., Xu, Y., & Che, W. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.036 · Cited by 87
Lejeune, S., Roy, C., Ciocea, V., Slimani, A., de Meester, C., Amzulescu, M. S., Pasquet, A., Vancraeynest, D., Beauloye, C., Vanoverschelde, J., et al. (2020) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2020.02.016 · Cited by 88
Varbo, A., & Nordestgaard, B. G. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.310269 · Cited by 83
Noto, T., Zhou, G., Schuele, S., Templer, J. W., & Zelano, C. (2018) · Chemical Senses · doi:10.1093/chemse/bjy045 · Cited by 92
Heart Failure With Preserved Ejection Fraction in the Young
Tromp, J., MacDonald, M. R., Tay, W. T., Teng, T. K., Hung, C., Narasimhan, C., Shimizu, W., Ling, L. H., Ng, T. P., Yap, J. J. L., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034720 · Cited by 86
Echevarria, C., Steer, J., Heslop-Marshall, K., Stenton, S., Hickey, P. M., Hughes, R. J., Wijesinghe, M., Harrison, R. N., Steen, N. D., Simpson, A. J., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209298 · Cited by 84
Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016
Saitoh, M., Ishida, J., Doehner, W., von Haehling, S., Anker, M. S., Coats, A. J. S., Anker, S. D., & Springer, J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.155 · Cited by 85
Self-citationGroot, H. E., Ali, L. A., van der Horst, I. C. C., Schurer, R. A. J., van der Werf, H. W., Lipšic, E., van Veldhuisen, D. J., Karper, J. C., & van der Horst, I. C. C. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1387-z · Cited by 88
Wagenaar, K. P., Broekhuizen, B. D., Jaarsma, T., Kok, I., Mosterd, A., Willems, F. F., Linssen, G. C. M., Agema, W. R. P., Anneveldt, S., Lucas, C. M. H. B., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1354 · Cited by 83
Self-citationLakhani, I., Wong, M. V., Hung, J. K. F., Gong, M., Waleed, K. B., Xia, Y., Lee, S., Roever, L., Liu, T., Tse, G., et al. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09927-x · Cited by 88
Cabac‐Pogorevici, I., Muk, B., Rustamova, Y., Kalogeropoulos, A. S., Tzeis, S. E., & Vardas, P. E. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1747 · Cited by 85
Piepoli, M. F., Hussain, R. I., Colet, J. C., Dosantos, R., Ferber, P. C., Jaarsma, T., & Edelmann, F. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2076 · Cited by 85
Intravenous Irons: From Basic Science to Clinical Practice
Bhandari, S., Pereira, D. I. A., Chappell, H. F., & Drakesmith, H. (2018) · Pharmaceuticals · doi:10.3390/ph11030082 · Cited by 88
Paolillo, S., Veglia, F., Salvioni, E., Corrà, U., Piepoli, M. F., Lagioia, R., Limongelli, G., Sinagra, G., Cattadori, G., Scardovi, A. B., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1364 · Cited by 84
Sugumar, H., Nanayakkara, S., Vizi, D., Wright, L. M., Chieng, D., Leet, A. S., Mariani, J. A., Voskoboinik, A., Prabhu, S., Taylor, A. J., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2122 · Cited by 84
ACC/AHA/HFSA 2022 and ESC 2021 Guidelines on Heart Failure Comparison
Behnoush, A. H., Khalaji, A., Naderi, N., Ashraf, H., & von Haehling, S. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14255 · Cited by 92
Electronic healthcare records and external outcome data for hospitalized patients with heart failure
Zhang, Z., Cao, L., Chen, R., Zhao, Y. D., Lv, L., Xu, Z., & Xu, P. (2021) · Scientific Data · doi:10.1038/s41597-021-00835-9 · Cited by 84
Lauritsen, J., Gustafsson, F., & Abdulla, J. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12283 · Cited by 83
Heart failure with preserved ejection fraction: present status and future directions
Yoon, S., & Eom, G. H. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0323-2 · Cited by 87
Vardeny, O., Claggett, B. L., Kachadourian, J., Pearson, S. M., Desai, A. S., Packer, M., Rouleau, J. L., Zile, M. R., Swedberg, K. B., Lefkowitz, M. P., et al. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004745 · Cited by 84
Pascual-Figal, D. A., Ferrero‐Gregori, A., Otero, I. G., Vázquez, R., Delgado, J. F., Garcia, J. A., Gimeno, J. R., Worner-Diz, F., Bardajı́, A., Alonso‐Pulpón, L., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.032 · Cited by 82
Self-citationEffects of boron-containing compounds on cardiovascular disease risk factors – A review
Donoiu, I., Militaru, C., Obleagă, O., Hunter, J. M., Neamţu, J., Biţă, A., Scorei, I. R., & Rogoveanu, O. C. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.06.003 · Cited by 86
Bosco‐Lévy, P., Duret, S., Picard, F., Santos, P. D. D., Puymirat, É., Gilleron, V., Blin, P., Châtellier, G., Looten, V., & Moore, N. D. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4690 · Cited by 83
Surkova, E., Muraru, D., Genovese, D., Aruta, P., Palermo, C., & Badano, L. P. (2019) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2019.06.009 · Cited by 82
Sierpiński, R., Josiak, K., Suchocki, T., Wojtas‐Polc, K., Mazur, G. J., Butrym, A. K., Rozentryt, P., van der Meer, P., Colet, J. C., von Haehling, S., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2036 · Cited by 86
Self-citationButt, J. H., Docherty, K. F., Jhund, P. S., de Boer, R. A., Böhm, M., Desai, A. S., Howlett, J. G., Inzucchi, S. E., Kosiborod, M., Martínez, F. A., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2381 · Cited by 83
Self-citationHarjola, V., Parissis, J., Rocca, H. B., Čelutkienė, J., Chioncel, O., Collins, S. P., Backer, D. D., Filippatos, G. S., Gayat, É., Hill, L., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1204 · Cited by 81
Self-citationMalnutrition, congestion and mortality in ambulatory patients with heart failure
Sze, S., Pellicori, P., Zhang, J., & Clark, A. L. (2018) · Heart · doi:10.1136/heartjnl-2018-313312 · Cited by 81
Banning, A. S., Adriaenssens, T., Berry, C., Bogaerts, K., Ērglis, A., Distelmaier, K., Guagliumi, G., Haine, S. E. F., Kastrati, A., Maßberg, S., et al. (2021) · EuroIntervention · doi:10.4244/eij-d-20-01076 · Cited by 81
The significance of left ventricular ejection time in heart failure with reduced ejection fraction
Alhakak, A. S., Teerlink, J. R., Lindenfeld, J. M., Böhm, M., Rosano, G. M. C., & Biering‐Sørensen, T. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2125 · Cited by 81
Self-citationLi, Z., Jin, X., Wu, T., Zhao, X., Wang, W., Lei, J., Pan, X., & Yan, N. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100069118 · Cited by 81
Eltrass, A. S., Tayel, M. B., & Ammar, A. I. (2022) · Neural Computing and Applications · doi:10.1007/s00521-022-06889-z · Cited by 88
Nauta, J. F., Hummel, Y. M., van Melle, J. P., van der Meer, P., Lam, C. S. P., Ponikowski, P. P., & Voors, A. A. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1058 · Cited by 80
Self-citationThe Role of Thyroid Hormones in Heart Failure
Vale, C., Neves, J. S., von Hafe, M., Borges‐Canha, M., & Leite-Moreira, A. F. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06870-4 · Cited by 78
Zhazykbayeva, S., Pabel, S., Mügge, A., Sossalla, S. T., & Hamdani, N. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00742-0 · Cited by 91
Heart failure with preserved ejection fraction: current management and future strategies
Tschöpe, C., Birner, C. M., Böhm, M., Bruder, O., Frantz, S., Luchner, A., Maier, L. S., Störk, S., Kherad, B., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1170-6 · Cited by 80
Myocarditis: An Interleukin-1-Mediated Disease?
De Luca, G., Cavalli, G., Campochiaro, C., Tresoldi, M., & Dagna, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01335 · Cited by 79
Jaarsma, T., Klompstra, L. V., Gal, T. B., Avraham, B. B., Boyne, J. J., Bäck, M., Chialà, O., Dickstein, K., Evangelista, L. S., Hagenow, A., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1754 · Cited by 79
Schauer, A., Draskowski, R., Jannasch, A., Kirchhoff, V., Goto, K., Männel, A., Barthel, P., Augstein, A., Winzer, E. B., Tugtekin, M., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12915 · Cited by 80
Lüsebrink, E., Orban, M. W., Kupka, D., Scherer, C., Hagl, C. M., Zimmer, S., Luedike, P., Thiele, H., Westermann, D., Maßberg, S., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa547 · Cited by 79
Tănase, D. M., Radu, S., Shurbaji, S. A., Baroi, G. L., Costea, C. F., Turliuc, M. D., Ouatu, A., & Floria, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112629 · Cited by 80
Moliner, P., Lupón, J., de Antonio, M., Domingo, M., Santiago‐Vacas, E., Zamora, E., Cediel, G., Santesmases, J., Díez, C., Troya, M. I., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1569 · Cited by 78
Miranda‐Silva, D., Wüst, R. C. I., Conceição, G., Gonçalves‐Rodrigues, P., Gonçalves, N., Gonçalves, A., Kuster, D. W. D., Leite-Moreira, A. F., van der Velden, J., Beleza, J., et al. (2019) · Acta Physiologica · doi:10.1111/apha.13378 · Cited by 77
Adamson, C., Jhund, P. S., Docherty, K. F., Bělohlávek, J., Chiang, C., Díez, M., Dróżdż, J., Dukát, A., Howlett, J. G., Ljungman, C. E. A., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2308 · Cited by 78
Self-citationA guide for assessment of myocardial stiffness in health and disease
Lizardi, J. C. V., Baranger, J., Nguyen, M. B., Asnacios, A., Malik, A., Lumens, J., Mertens, L., Friedberg, M. K., Simmons, C. A., Pernot, M., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-021-00007-3 · Cited by 85
Sleep apnoea and heart failure
Levy, P. A., Naughton, M. T., Tamisier, R., Cowie, M., & Bradley, T. D. (2021) · European Respiratory Journal · doi:10.1183/13993003.01640-2021 · Cited by 82
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J. M., Capodanno, D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.016 · Cited by 89
Self-citationWhich Patients with Heart Failure Should Receive Specialist Palliative Care?
Campbell, R. T., Petrie, M. C., Jackson, C. E., Jhund, P. S., Wright, A., Gardner, R. S., Sonecki, P., Pozzi, A., McSkimming, P., McConnachie, A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1240 · Cited by 78
Stone, J., Perue, R. K., Abbasi, M. A., & Akhtari, M. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00924 · Cited by 78
Johansson, P., Westas, M., Andersson, G., Alehagen, U., Broström, A., Jaarsma, T., Mourad, G., & Lundgren, J. (2019) · JMIR Mental Health · doi:10.2196/14648 · Cited by 77
Onishi, K. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.03.001 · Cited by 77
Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
Akhtar, M. M., & Elliot, P. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1236-3 · Cited by 77
Zimpfer, D., Gustafsson, F., Potapov, E. V., Pya, Y., Schmitto, J. D., Berchtold‐Herz, M., Morshuis, M., Shaw, S. M., Saeed, D., Ii Jacob Lavee, I., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehaa639 · Cited by 77
Akhtar, M. M., Lorenzini, M., Pavlou, M., Ochoa, J. P., O’Mahony, C., Restrepo-Córdoba, M. A., Segura-Rodríguez, D., Bermúdez-Jiménez, F. J., Molina, P., Cuenca, S., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.1106 · Cited by 77
Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease
Georgianos, P. I., & Agarwal, R. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.05.027 · Cited by 84
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Tonelli, M. A., Berns, J. B., Bozkurt, B., Cheung, R., Cuevas, Y., Effa, E. E., Eisenga, M. F., Fishbane, S., Ginzburg, Y. Z., Haase, V. H., et al. (2026) · Kidney International · doi:10.1016/j.kint.2025.06.006 · Cited by 99
Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF
Savarese, G., Orsini, N., Hage, C., Vedin, O., Cosentino, F., Rosano, G. M. C., Dahlström, U., & Lund, L. H. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2017.12.014 · Cited by 77
Self-citationPeng, S., Huang, J., Liu, X., Deng, J., Sun, C., Tang, J., Chen, H., Cao, W., Wang, W., Duan, X., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.994359 · Cited by 79
Zhou, W., Brown, J. M., Bajaj, N. S., Chandra, A., Divakaran, S., Weber, B., Bibbo, C. F., Hainer, J. M., Taqueti, V. R., Dorbala, S., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa191 · Cited by 75
A Swedish Nationwide Adoption Study of the Heritability of Heart Failure
Lindgren, M. P., Pirouzifard, M., Smith, J. G., Sundquist, J., Sundquist, K., & Zöller, B. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.1919 · Cited by 69
Giuşcă, S., Korosoglou, G., Zieschang, V., Stoiber, L., Schnackenburg, B., Stehning, C., Gebker, R., Pieske, B. M., Schuster, A., Backhaus, S. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32226-3 · Cited by 75
Self-citationClinical Utility of Procalcitonin in the Diagnosis of Pneumonia
Wussler, D. N., Kozhuharov, N., de Oliveira, M. T., Bossa, A. S., Sabti, Z., Nowak, A., Murray, K., de Lavallaz, J. D. F., Badertscher, P., Twerenbold, R., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.306787 · Cited by 76
Myocarditis in athletes: A clinical perspective
Halle, M., Binzenhöfer, L., Mahrholdt, H., Schindler, M., Esefeld, K., & Tschöpe, C. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320909670 · Cited by 75
Biegus, J., Zymliński, R., Testani, J. M., Marciniak, D. M., Zdanowicz-Ratajczyk, A., Jankowska, E. A., Banasiak, W., & Ponikowski, P. P. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2053 · Cited by 75
Self-citationVerhaert, D. V. M., Rocca, H. B., van Veldhuisen, D. J., & Vernooy, K. (2020) · EP Europace · doi:10.1093/europace/euaa368 · Cited by 78
dos Santos, M. R., Saitoh, M., Ebner, N., Valentová, M., Konishi, M., Ishida, J., Emami, A., Springer, J., Sandek, A., Doehner, W., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.09.006 · Cited by 74
Self-citationThe microRNA-29/PGC1α regulatory axis is critical for metabolic control of cardiac function
Caravia, X. M., Fanjul, V., Oliver, E., Roiz‐Valle, D., Morán-Álvarez, A., Desdín-Micó, G., Mittelbrunn, M., Cabo, R., Vega, J. A., Rodríguez, F. J., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006247 · Cited by 72
Self-citationBell, D. S. H., & Gonçalves, E. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13652 · Cited by 75
Muiesan, M. L., Salvetti, M., Virdis, A., Masi, S., Casiglia, E., Tikhonoff, V., Barbagallo, C. M., Bombelli, M., Cicero, A. F. G., Círillo, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002589 · Cited by 74
Metadata
- Authors
- Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M. C., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., van der Meer, P., Authors/Task Force Members, & Reviewers, D.
- Affiliations
- Wroclaw Medical University (PL)
- Corresponding author
- Ponikowski, Piotr
- Voors, Adriaan A.
- ORCID
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-05-20
- Volume
- 18
- Issue
- 8
- Pages
- 891-975
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W4293860347
- Cited by
- 5,866
- References
- 656
- Citations by year
- 2026: 85 · 2025: 205 · 2024: 317 · 2023: 386 · 2022: 601 · 2021: 894 · 2020: 965 · 2019: 881 · 2018: 763 · 2017: 615 · 2016: 145
- FWCI
- 659.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- European Journal of Heart Failure (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- ORBi (University of Liège) (submittedVersion, other-oa)
- GRO (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- American Heart Association
- American College of Cardiology Foundation
- National Institute for Health and Care Research (NF-SI-0611-10227)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- heart failure, acute heart failure, chronic heart failure, diagnosis, treatment, European Society of Cardiology, risk-benefit assessment
- MeSH terms
- Acute Disease, Assisted Circulation, Cardiovascular Agents, Chronic Disease, Heart Failure, Heart Function Tests, Humans, Stroke Volume, Heart Transplantation, Cardiac Imaging Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
